结构特征5-替代Pyrrolo[3,2-d]pyrimidine抗叶酸抑制剂与人血清氧甲基转移酶2复合的结构特征
Jade M Katinas1, Md Junayed Nayeen2, Mathew Schneider3
1Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States.
Biochemistry
|February 7, 2024
概括
我们确定了新型抗叶剂的关键结构特征,这些抗叶剂增强了它们对抗癌症治疗的素基甲基转移酶2 (SHMT2) 的功效,这是癌症治疗的目标. 这些发现引导了开发更有效的抗瘤药物的研究.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药用化学 医学化学
背景情况:
- 此前发现的 pyrrolo[3,2-d]pyrimidine抗叶剂通过抑制氨酸氧甲基转移酶2 (SHMT2) 来表现出强烈的抗瘤活性.
- 了解SHMT2抑制的结构基础对于优化这些新型抗癌剂至关重要.
研究的目的:
- 将SHMT2的晶体结构与扩展系列的pyrrolo[3,2-d]pyrimidine抑制剂复合呈现.
- 为了将结构特征与抑制剂强度相关联,并研究特定突变和多重氨基化的影响.
主要方法:
- 用X射线结晶学来确定SHMT2抑制剂复合物的结构.
- 酶动态分析和基于细胞的测定 (HCT116) 来评估抑制剂的强度和细胞效应.
- 抑制剂变异的结构-活性关系 (SAR) 分析 (桥梁长度,芳香环,多重胺化).
主要成果:
- 确定了5碳桥的长度作为pyrrolo[3,2-d]pyrimidine抑制剂对SHMT2.2的强度的关键决定因素.
- 证明Tyr105在SHMT2中的突变增强了抑制剂的功效和细胞生长抑制.
- 提供了第一个结构性洞察力,了解多重胺抗叶酸与人类SHMT2.2的相互作用.
结论:
- 这项研究阐明了由pyrrolo[3,2-d]pyrimidine抗叶酸结合SHMT2的关键结构决定因素.
- 这些发现支持将这些化合物作为新型抗瘤剂的发展,强调了桥梁长度和特定氨基酸相互作用的重要性.
- 与SHMT2发生的多聚胺抗叶酸相互作用的结构性表征为药物设计提供了新的途径.
更多相关视频
05:17Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.6K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
相关概念视频
01:19Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
01:25Basicity of Heterocyclic Aromatic Amines
6.0K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.0K
01:17Phase II Reactions: Methylation Reactions
191
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
191